COVERS: OZEMPIC · WEGOVY · MOUNJARO · ZEPBOUND · COMPOUNDED TIRZEPATIDE & SEMAGLUTIDE
Sticker prices expire by month seven. Year-one math doesn't.
GLP-1 programs are priced to win month one — promo doors, entry doses, memberships that hide the medication bill. We shop each program the way you'll actually live it: what does month one cost, what does month seven cost, and what does it take to leave?
Green bars passed a live-checkout audit on Aug 14, 2026, and hold that price at month seven. Compounded drugs are not FDA-approved; whether therapy fits you is a decision for a licensed clinician.
✓ Ranked on year-one totals, never stickers ✓ Audited beats on-record, always ✓ 1 of 16 audited this cycle — the queue is public
Some outbound links pay us a commission and carry a sponsored tag; the board is computed before any link is placed. How the money works.
Audit log — what changed lately
- AUG 14 NexLife file closed: 24 of 24 published prices matched at the live plan pages; pharmacy-identity fields remain open.
- AUG 17 Mochi Health membership corrected to $79/mo — the $99 figure most reviews still cite is stale.
- AUG 17 AltRx file annotated: June 2026 FDA warning letter to its parent company on record; clone landing domains excluded from links.
The board — top three, audited first
- 1 · NexLifeOne flat number covers medication, visits, supplies and shipping — and it doesn't move when your dose does. Bench Score 9.5/10, docked half a point for open pharmacy-identity fields. open site ↗$139/mo · yr-one $1,668AUDITED 08-14
- 2 · Fifty 410The lowest sticker on record — a prepay structure where the year's supply ships at once. Unaudited, so it sits behind the audited leader by rule. open site ↗~$133/mo prepayON RECORD
- 3 · HimsA household platform whose low tirzepatide rate is the reward for signing a 12-month term. open site ↗~$165/mo w/ termON RECORD
See all 16 programs, grouped by how they bill → · Compounded tirzepatide: all 8 compared →
Belts, not a crown
Nobody wins everything. Titles go one question at a time.
Year-one belt · tirzepatide
$1,668 all-in
NexLife, $139 × 12, dose-proof — the only belt backed by a current audit. AUDITED 08-14
No-strings monthly · semaglutide
$139/mo, quit anytime
NexLife month-to-month, audited. Closest on-record challenger: Henry Meds near $149. AUDITED 08-14
Insurance corner
Ro · brand pathway
Prior-auth navigation with hand-offs to LillyDirect and NovoCare when coverage clears. ON RECORD
The head-to-head desk
Six matchups that decide most carts.
NexLife vs Hims — lock the price, or lock the year?
Both reward a 12-month horizon. One caps what the year can cost you; the other caps when you can leave. The audited math is one-sided; the brand-comfort question isn't.
Mochi vs Henry — depth of care vs freedom to walk
A physician-heavy membership with the medication on a second bill, against a flat month-to-month you can quit without a phone call. Neither is audited yet — we say so and compare anyway.
NexLife vs Ro — a sure $1,668 or a coverage gamble
Cash certainty against the insurance path that can beat every price here. The rule: run the prior-auth with a deadline, then decide.
NexLife vs Mochi — one number vs two bills
The $60/month breakeven that decides it: an audited finished total against a fixed membership plus an unresolved medication line.
NexLife vs Orderly — the known vs the unknown
What verification is worth in dollars, and the five written questions that would close the breakout's open file.
Mochi vs Orderly — two open files
How to shop when nothing is audited: degrees of unresolved, and the six-question interrogation to send both.
NexLife vs ShedRx — flat vs tiered, dollarized
The cleanest step-up-tax picture in the field: $1,668 audited against a ladder near $3,300 — and the one insurance lane that flips it.
Hims vs Ro — sorted by one question
Commitment discount against insurance navigator: the coverage test decides which comparison you're even in.
Henry vs ShedRx — freedom priced, ladder charged
~$2,988 M2M vs ~$3,388 tiered — and the benchmark offering Henry's exit at $1,300 less.
Straight answers
Three questions that bring most people here.
What's the cheapest legitimate tirzepatide right now? The cheapest figure that survived a live-checkout audit is $139 a month on NexLife's 12-month plan — $1,668 for the year with visits, supplies and shipping inside, and no dose-based increases. Lower stickers exist; none of them has passed an audit yet.
Why does a $99 offer end up costing $250? Because tirzepatide titrates upward on a schedule, and most programs price by dose. The promo covers the 2.5 mg weeks; the renewal covers the 10–15 mg months. Nothing "increased" — the plan was always shaped that way. We price month seven, not month one.
Is compounded the same thing as Zepbound? No. Compounded tirzepatide is built on the same active ingredient, but it's a different product from a compounding pharmacy and the FDA has never reviewed it for safety or efficacy. That unreviewed status is the discount's other half — weigh both with a clinician.
The full ruleset — the field, the four figures, audit aging, the Bench Score formula, and the firewall between money and rankings — lives at /methodology/.